Robert E. Schoen

25.4k total citations · 4 hit papers
234 papers, 10.7k citations indexed

About

Robert E. Schoen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Robert E. Schoen has authored 234 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Oncology, 80 papers in Pulmonary and Respiratory Medicine and 74 papers in Pathology and Forensic Medicine. Recurrent topics in Robert E. Schoen's work include Colorectal Cancer Screening and Detection (124 papers), Gastric Cancer Management and Outcomes (69 papers) and Genetic factors in colorectal cancer (67 papers). Robert E. Schoen is often cited by papers focused on Colorectal Cancer Screening and Detection (124 papers), Gastric Cancer Management and Outcomes (69 papers) and Genetic factors in colorectal cancer (67 papers). Robert E. Schoen collaborates with scholars based in United States, United Kingdom and Canada. Robert E. Schoen's co-authors include Joel L. Weissfeld, Paul F. Pinsky, Richard B. Hayes, Uri Ladabaum, Linda Rabeneck, Graeme P. Young, Eline H. Schreuders, Joseph J.�Y. Sung, Ernst J. Kuipers and Arlinda Ruco and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Robert E. Schoen

221 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colorectal cancer screening: a global overview of existing programmes

2015 943 citations Linda Rabeneck, Robert E. Schoen et al. profile →
Lack of Effect of a Low-Fat, High-Fiber Diet on the Recurrence of Colorectal Adenomas

2000 640 citations Arthur Schatzkin, Elaine Lanza et al. profile →
Strategies for Colorectal Cancer Screening

2019 414 citations Uri Ladabaum, Jason A. Dominitz et al. Gastroenterology profile →
Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy

2024 45 citations Uri Ladabaum, Ajitha Mannalithara et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert E. Schoen United States	55	6.6k	3.9k	2.8k	2.0k	1.9k	234	10.7k
Robert S. Bresalier United States	58	4.4k 0.7×	2.3k 0.6×	2.1k 0.7×	2.5k 1.3×	4.2k 2.3×	253	13.2k
Dennis J. Ahnen United States	41	5.9k 0.9×	3.3k 0.8×	2.6k 0.9×	1.8k 0.9×	2.0k 1.1×	93	9.3k
Jean Faivre France	59	7.6k 1.2×	3.8k 1.0×	3.1k 1.1×	3.9k 1.9×	1.3k 0.7×	353	13.3k
Joel L. Weissfeld United States	60	4.0k 0.6×	3.3k 0.9×	1.5k 0.6×	1.1k 0.6×	2.1k 1.1×	211	10.3k
Bernard Levin United States	46	6.4k 1.0×	3.4k 0.9×	3.1k 1.1×	2.6k 1.3×	1.7k 0.9×	165	11.1k
Dale C. Snover United States	52	8.3k 1.3×	5.4k 1.4×	4.7k 1.7×	3.1k 1.5×	1.2k 0.7×	163	13.8k
Monica M. Bertagnolli United States	60	5.7k 0.9×	3.2k 0.8×	3.6k 1.3×	2.4k 1.2×	3.2k 1.7×	201	13.4k
Paul J. Limburg United States	48	3.8k 0.6×	1.4k 0.4×	2.2k 0.8×	1.4k 0.7×	1.6k 0.8×	266	7.3k
James E. Krook United States	52	10.2k 1.6×	5.8k 1.5×	1.4k 0.5×	3.1k 1.6×	2.5k 1.3×	136	14.6k
Paul Lochhead United States	41	3.7k 0.6×	1.6k 0.4×	1.8k 0.6×	1.6k 0.8×	3.2k 1.7×	101	8.7k

Countries citing papers authored by Robert E. Schoen

Since Specialization

Citations

This map shows the geographic impact of Robert E. Schoen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Schoen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Schoen more than expected).

Fields of papers citing papers by Robert E. Schoen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Schoen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Schoen. The network helps show where Robert E. Schoen may publish in the future.

Co-authorship network of co-authors of Robert E. Schoen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Schoen. A scholar is included among the top collaborators of Robert E. Schoen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Schoen. Robert E. Schoen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schoen, Robert E., et al.. (2025). Colonoscopy versus faecal immunochemical testing in COLONPREV. The Lancet. 406(10509). 1218–1219.

Diergaarde, Brenda, Greg Young, David W. Hall, et al.. (2025). Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α‐CORRECT Study. Journal of Surgical Oncology. 132(1). 175–186. 3 indexed citations

Juul, Frederik Emil, Amanda J. Cross, Robert E. Schoen, et al.. (2024). Effectiveness of Colonoscopy Screening vs Sigmoidoscopy Screening in Colorectal Cancer. JAMA Network Open. 7(2). e240007–e240007. 14 indexed citations

Saul, Melissa, et al.. (2024). Multitarget Stool DNA Testing for Colorectal Cancer Screening in Clinical Practice. The American Journal of Gastroenterology. 120(10). 2415–2421. 1 indexed citations

Ladabaum, Uri, Ajitha Mannalithara, Yingjie Weng, et al.. (2024). Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy. Gastroenterology. 167(2). 378–391. 45 indexed citations breakdown →

Cameron, Cheryl, Vineet K. Raghu, Brian Richardson, et al.. (2024). Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention. Frontiers in Immunology. 15. 1437391–1437391.

Ladabaum, Uri, Ajitha Mannalithara, Yingjie Weng, et al.. (2024). Sa1146 COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF COLORECTAL CANCER (CRC) SCREENING WITH BLOOD-BASED BIOMARKERS (LIQUID BIOPSY) VS. FECAL TESTS OR COLONOSCOPY. Gastroenterology. 166(5). S–359. 1 indexed citations

Yu, Ming, Kelly Carter, Kelsey K. Baker, et al.. (2023). Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas. Cancer Epidemiology Biomarkers & Prevention. 32(9). 1146–1152. 3 indexed citations

Yu, Yi‐Chuan, Pedram Paragomi, Aizhen Jin, et al.. (2022). Dietary Nonstarch Polysaccharide Intake and Risk of Colorectal Cancer: Findings from the Singapore Chinese Health Study. Cancer Research Communications. 2(10). 1304–1311. 4 indexed citations

10.

Juul, Frederik Emil, Amanda J. Cross, Robert E. Schoen, et al.. (2022). 15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality. Annals of Internal Medicine. 175(11). 1525–1533. 27 indexed citations

11.

Melson, Joshua, Thomas F. Imperiale, Steven H. Itzkowitz, et al.. (2020). AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States. Clinical Gastroenterology and Hepatology. 18(12). 2667–2678.e2. 24 indexed citations

12.

Tan, Xiao, Jingshan Tong, Yi‐Jun Wang, et al.. (2019). BET Inhibitors Potentiate Chemotherapy and Killing of SPOP -Mutant Colon Cancer Cells via Induction of DR5. Cancer Research. 79(6). 1191–1203. 45 indexed citations

13.

Wang, Xiaoliang, Andrew T. Chan, Martha L. Slattery, et al.. (2018). Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk. Cancer Research. 78(16). 4790–4799. 26 indexed citations

14.

Leibowitz, Brian J., Liheng Yang, Wei Liang, et al.. (2018). Targeting p53-dependent stem cell loss for intestinal chemoprotection. Science Translational Medicine. 10(427). 42 indexed citations

15.

Kimura, Takashi, John McKolanis, Kazi Islam, et al.. (2012). MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study. Cancer Prevention Research. 6(1). 18–26. 186 indexed citations

16.

Berndt, Sonja I., Wen‐Yi Huang, Matthew Yeager, et al.. (2007). Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis. 28(9). 1965–1970. 35 indexed citations

17.

Hur, Chin, Daniel C. Chung, Robert E. Schoen, & G. Scott Gazelle. (2007). The Management of Small Polyps Found by Virtual Colonoscopy: Results of a Decision Analysis. Clinical Gastroenterology and Hepatology. 5(2). 237–244. 46 indexed citations

18.

Sass, David A., Robert E. Schoen, Joel L. Weissfeld, et al.. (2004). Relationship of Visceral Adipose Tissue to Recurrence of Adenomatous Polyps. The American Journal of Gastroenterology. 99(4). 687–693. 38 indexed citations

19.

Pinsky, Paul F., Robert E. Schoen, Joel L. Weissfeld, et al.. (2003). Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. Clinical Gastroenterology and Hepatology. 1(2). 103–110. 26 indexed citations

20.

Schoen, Robert E., Vijayan Balan, William B. Silverman, et al.. (1998). Diagnosing cholangiocarcinoma (CCA) in primary sclerosing cholangitis (PSC): The role of brush cytology (BC) and serum tumor markers.. Gastrointestinal Endoscopy. 47(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact